• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病大脑中蛋白激酶C活性减弱及易位

Attenuated protein kinase C activity and translocation in Alzheimer's disease brain.

作者信息

Wang H Y, Pisano M R, Friedman E

机构信息

Department of Psychiatry, Medical College of Pennsylvania, Philadelphia 19129.

出版信息

Neurobiol Aging. 1994 May-Jun;15(3):293-8. doi: 10.1016/0197-4580(94)90023-x.

DOI:10.1016/0197-4580(94)90023-x
PMID:7936052
Abstract

Protein kinase C (PKC) activity and its redistribution were determined in postmortem Alzheimer's disease (AD) and age-matched control brains. Cytosolic and membrane-associated PKC activities were lower in frontal and temporal cortices and hippocampi of AD brains. Increased concentrations of phosphatidyl-L-serine, Ca2+ or phorbol 12-myristate, 13-acetate only weakly increased enzyme activity in AD tissues. Redistribution of cytosolic PKC to the membranous fraction was elicited in control brain slices by 162 nM PMA in the presence of K+ (65 mM). This redistribution of the enzyme was markedly reduced in AD brain slices. In contrast, the immunoreactivity of the alpha- and gamma-PKC isozymes were elevated in cortical tissue from AD subjects. No changes were noted in beta-PKC immunoreactivity. These results suggest that the reduced PKC activity and the attenuated translocation of the enzyme in AD brain tissue may be attributed to down regulation of PKC or to alteration in PKC protein. The increase in PKC immunoreactivity may be a reflection of an altered susceptibility to proteolysis or a compensatory response secondary to the loss in enzyme activity.

摘要

在阿尔茨海默病(AD)患者的死后大脑以及年龄匹配的对照大脑中,测定了蛋白激酶C(PKC)的活性及其重新分布情况。AD大脑额叶和颞叶皮质以及海马体中的胞质和膜相关PKC活性较低。磷脂酰-L-丝氨酸、Ca2+或佛波醇12-肉豆蔻酸酯13-乙酸酯浓度的增加仅微弱地增加了AD组织中的酶活性。在存在K+(65 mM)的情况下,162 nM佛波酯(PMA)可促使对照脑片中的胞质PKC重新分布到膜部分。在AD脑片中,这种酶的重新分布明显减少。相比之下,AD受试者皮质组织中α-PKC和γ-PKC同工酶的免疫反应性升高。β-PKC免疫反应性未观察到变化。这些结果表明,AD脑组织中PKC活性降低和酶的易位减弱可能归因于PKC的下调或PKC蛋白的改变。PKC免疫反应性的增加可能反映了对蛋白水解敏感性的改变或酶活性丧失后的代偿反应。

相似文献

1
Attenuated protein kinase C activity and translocation in Alzheimer's disease brain.阿尔茨海默病大脑中蛋白激酶C活性减弱及易位
Neurobiol Aging. 1994 May-Jun;15(3):293-8. doi: 10.1016/0197-4580(94)90023-x.
2
Lithium treatment inhibits protein kinase C translocation in rat brain cortex.锂治疗可抑制大鼠大脑皮层中蛋白激酶C的易位。
Psychopharmacology (Berl). 2001 Oct;158(1):80-6. doi: 10.1007/s002130100834.
3
Assessment of protein kinase C isozymes by two-site enzyme immunoassay in human brains and changes in Alzheimer's disease.通过双位点酶免疫测定法评估人脑中的蛋白激酶C同工酶以及阿尔茨海默病中的变化。
Neurology. 1993 Jul;43(7):1407-13. doi: 10.1212/wnl.43.7.1407.
4
Characterization and differential distribution of the three major human protein kinase C isozymes (PKC alpha, PKC beta, and PKC gamma) of the central nervous system in normal and Alzheimer's disease brains.正常和阿尔茨海默病大脑中枢神经系统中三种主要人类蛋白激酶C同工酶(PKCα、PKCβ和PKCγ)的特性及差异分布
Lab Invest. 1991 Jan;64(1):35-44.
5
Parathyroid hormone causes translocation of protein kinase-C from cytosol to membranes in rat osteosarcoma cells.甲状旁腺激素可导致大鼠骨肉瘤细胞中的蛋白激酶-C从胞质溶胶转移至细胞膜。
Endocrinology. 1989 Mar;124(3):1107-13. doi: 10.1210/endo-124-3-1107.
6
Implication of protein kinase C in mechanisms of potassium-induced long-term potentiation in rat hippocampal slices.蛋白激酶C在大鼠海马脑片钾离子诱导的长时程增强机制中的作用
Brain Res. 1997 Jan 16;745(1-2):222-30. doi: 10.1016/s0006-8993(96)01155-9.
7
Enhanced protein kinase C activity and translocation in bipolar affective disorder brains.双相情感障碍患者大脑中蛋白激酶C活性增强及转位
Biol Psychiatry. 1996 Oct 1;40(7):568-75. doi: 10.1016/0006-3223(95)00611-7.
8
Ca2+-dependent and Ca2+-independent protein kinase C changes in the brain of patients with Alzheimer's disease.阿尔茨海默病患者大脑中钙依赖和非钙依赖的蛋白激酶C变化。
J Neurochem. 1996 Jul;67(1):317-23. doi: 10.1046/j.1471-4159.1996.67010317.x.
9
Cerebral microvessels in Alzheimer's have reduced protein kinase C activity.阿尔茨海默病患者的脑微血管中蛋白激酶C活性降低。
Neurobiol Aging. 1995 Jul-Aug;16(4):563-9. doi: 10.1016/0197-4580(95)00048-j.
10
Subcellular distribution of protein kinase C alpha and betaI in bovine spermatozoa, and their regulation by calcium and phorbol esters.蛋白激酶Cα和βI在牛精子中的亚细胞分布及其受钙和佛波酯的调节
Biol Reprod. 1997 Feb;56(2):454-9. doi: 10.1095/biolreprod56.2.454.

引用本文的文献

1
A high-performance genetically encoded sensor for cellular imaging of PKC activity in vivo.一种用于体内PKC活性细胞成像的高性能基因编码传感器。
Nat Commun. 2025 Jul 10;16(1):6378. doi: 10.1038/s41467-025-61729-7.
2
Elevated CSF GAP-43 in Mild Cognitive Impairment Linked to Cognitive Impairment Through Increased Amyloid-β Accumulation, with a Shift to Reduced Amyloid-β Accumulation in Alzheimer's Disease.轻度认知障碍患者脑脊液中生长相关蛋白43(GAP-43)升高,通过淀粉样β蛋白(Aβ)积累增加与认知障碍相关,而在阿尔茨海默病中则转变为Aβ积累减少。
J Mol Neurosci. 2025 Mar 20;75(2):39. doi: 10.1007/s12031-025-02333-8.
3
Renin-angiotensin system inhibitors positively impact on multiple aging regulatory pathways: Could they be used to protect against human aging?
肾素-血管紧张素系统抑制剂对多种衰老调控途径有积极影响:它们可用于预防人类衰老吗?
Physiol Rep. 2024 Jun;12(12):e16094. doi: 10.14814/phy2.16094.
4
The effects of carvacrol and p-cymene on Aβ -induced long-term potentiation deficit in male rats.香芹酚和对伞花烃对雄性大鼠 Aβ 诱导的长时程增强缺陷的影响。
CNS Neurosci Ther. 2024 Mar;30(3):e14459. doi: 10.1111/cns.14459. Epub 2023 Sep 19.
5
The role of PKC/PKR in aging, Alzheimer's disease, and perioperative neurocognitive disorders.蛋白激酶C/蛋白激酶R在衰老、阿尔茨海默病及围手术期神经认知障碍中的作用
Front Aging Neurosci. 2022 Sep 12;14:973068. doi: 10.3389/fnagi.2022.973068. eCollection 2022.
6
Zinc in Regulating Protein Kinases and Phosphatases in Neurodegenerative Diseases.锌在神经退行性疾病中对蛋白激酶和磷酸酶的调节作用。
Biomolecules. 2022 Jun 4;12(6):785. doi: 10.3390/biom12060785.
7
Synaptic dysregulation and hyperexcitability induced by intracellular amyloid beta oligomers.细胞内淀粉样β寡聚体诱导的突触失调和过度兴奋。
Aging Cell. 2021 Sep;20(9):e13455. doi: 10.1111/acel.13455. Epub 2021 Aug 19.
8
GAP-43 and BASP1 in Axon Regeneration: Implications for the Treatment of Neurodegenerative Diseases.生长相关蛋白43和脑酸性可溶性蛋白1在轴突再生中的作用:对神经退行性疾病治疗的启示
Front Cell Dev Biol. 2020 Sep 3;8:567537. doi: 10.3389/fcell.2020.567537. eCollection 2020.
9
Plasmalogens, platelet-activating factor and beyond - Ether lipids in signaling and neurodegeneration.醚脂类在信号转导和神经退行性变中的作用:血小板激活因子和其他相关物质。
Neurobiol Dis. 2020 Nov;145:105061. doi: 10.1016/j.nbd.2020.105061. Epub 2020 Aug 28.
10
NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases.NRF2 调控机制作为神经退行性疾病潜在药物靶点的研究进展。
Biomolecules. 2020 Jun 14;10(6):904. doi: 10.3390/biom10060904.